Leroy Seafood Group ASA (0GM2)
London Exchange · UK · prices in NOK · close of 21 Oct 2026
Key indicators
| Last close | NOK 43.30 |
|---|---|
| 52-week range | 37.92 – 49.47 |
| Return, 1 month / 3 months | +5.6% / +6.4% |
| Return, 1 year / 3 years | −12.0% / +19.3% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 22.2% |
| Worst drawdown (1 year) | -22.2% |
| Average daily value traded | 1.46M NOK |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Leroy Seafood Group is a Norwegian seafood company based in Bergen. It farms salmon and trout, processes and sells wild-caught fish and shellfish, and offers value-added seafood products. Its customers include retailers, food service operators and seafood distributors in Norway and in export markets. The group operates through farming, processing and sales operations, and its products reach consumers under brands tied to the Leroy name and to Norwegian seafood more broadly.
Leroy Seafood Group ASA trades under the code 0GM2 on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Leroy Seafood Group ASA (0GM2) trades on the London Exchange in UK. It last closed at NOK 43.30 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,568 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.0% and over the last three months it rose 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -0.4% | ||
| From 52-week high | -11.2% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 6.4% | ||
| 6-month return | -1.1% | ||
| 12-month return, skipping the last month | -16.6% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.2% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.46M NOK | ||
| Zero-volume days | 10.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +5.6% |
| 3 months | +6.4% |
| 6 months | −1.1% |
| 1 year | −12.0% |
| 3 years | +19.3% |
| 5 years | −29.5% |
Signals
| 50-day / 200-day average | 42.88 / 43.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | NOK 2.5000 |
| 27 May 2025 | NOK 2.5000 |
| 29 May 2024 | NOK 2.5000 |
| 24 May 2023 | NOK 2.5000 |
| 24 May 2022 | NOK 2.5000 |
| 27 May 2021 | NOK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.